Annual report [Section 13 and 15(d), not S-K Item 405]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Narrative)

v3.25.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES      
Research and development tax credits $ 1,349,000 $ 1,206,000  
Federally insured limit amount 250,000    
Cash and cash equivalents 2,338,000 2,815,000 $ 6,888,000
Marketable securities outstanding balance 0 $ 7,611,000  
Amount in excess of FDIC insurance amount $ 1,838